009: CMC Considerations For In-Human Studies with Drs. Edith Perez & Nathan Ihle
Business Of Biotech
00:00
Introduction
Bolt Biotherapeutics CEO Randy Schatzmann talks about how he's keeping the money train rolling. Dr. Edith Perez, who just joined Bolt as Chief Medical Officer and Dr. Nathan Ile, who recently took the post of VP of CMC and quality are our guests. The pair will discuss patient-centricity considerations for first human in human studies.
Play episode from 00:00
Transcript
